The round was led by General Catalyst, with participation from returning investors AlleyCorp, Baukunst, Village Global, and Ubiquity Ventures.

Eyebot is transforming how people access vision care. Its 90-second vision test helps patients get the prescriptions they need-fast, affordably, and without the need for insurance or appointments. Every test is reviewed by a licensed eye doctor to ensure accuracy and clinical oversight. With a mission to make vision care accessible to everyone, equally, at the touch of a button, Eyebot is pioneering a new future for vision care.